14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of LABS.TO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Tuesday for Medipharm Labs Corp. stock after losing 0%
(Updated on Apr 23, 2024)

Sell candidate since Apr 22, 2024 PDF

No changes to the price of Medipharm Labs Corp. stock on the last trading day (Tuesday, 23rd Apr 2024). During the last trading day the stock fluctuated 6.67% from a day low at $0.0750 to a day high of $0.0800. The price has fallen in 4 of the last 10 days and is down by -11.76% for this period.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.0713 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 21.61% during the next 3 months and, with a 90% probability hold a price between $0.0868 and $0.122 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

LABS.TO Signals & Forecast

There are few to no technical positive signals at the moment. The Medipharm Labs Corp. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.0779 and $0.0767. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, March 26, 2024, and so far it has fallen -21.05%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Medipharm Labs Corp. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0700 and $0.0650. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $0.0650 may give a huge drop in the stock price.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0050 between high and low, or 6.67%. For the last week the stock has had daily average volatility of 6.67%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LABS.TO) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Medipharm Labs Corp. to open at $0.0767, and during the day (based on 14 day Average True Range), to move between $0.0688 and $0.0812, which gives a possible trading interval of +/-$0.0062 (+/-8.27%) up or down from last closing price. If Medipharm Labs Corp. takes out the full calculated possible swing range there will be an estimated 16.55% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0700 (6.67%) than the resistance at $0.0800 (6.67%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Medipharm Labs Corp. stock A Buy?

The Medipharm Labs Corp. stock holds several negative signals and despite the positive trend, we believe Medipharm Labs Corp. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.313 Sell Candidate Unchanged

Predicted Opening Price for Medipharm Labs Corp. of Wednesday, April 24, 2024

Fair opening price April 24, 2024 Current price
$0.0767 ( 2.22%) $0.0750

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for LABS.TO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0817 8.89 %
R2 0.0798 6.34 %
R1 0.0786 4.77 %
Current price: 0.0750
Support S1 0.0748 -0.324 %
S2 0.0736 -1.90 %
S3 0.0717 -4.44 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0900 20.00 %
R2 0.0850 13.33 %
R1 0.0800 6.67 %
Current price 0.0750
Support S1 0.0700 -6.67%
S2 0.0650 -13.33%
S3 0 .

FAQ

What is the symbol for Medipharm Labs Corp. Stock and on which exchange is it traded?
The symbol for Medipharm Labs Corp. is LABS.TO and it is traded on the TSX (Toronto Stock Exchange).

Should I buy or sell Medipharm Labs Corp. Stock?
The Medipharm Labs Corp. stock holds several negative signals and despite the positive trend, we believe Medipharm Labs Corp. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Medipharm Labs Corp. Stock?
Medipharm Labs Corp. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Medipharm Labs Corp. Stock.

What's the current price of Medipharm Labs Corp. Stock?
As of the end of day on the Apr 23, 2024, the price of an Medipharm Labs Corp. (LABS.TO) share was $0.0750.

What is the 52-week high and low for Medipharm Labs Corp. Stock?
The 52-week high for Medipharm Labs Corp. Stock is $0.100 and the 52-week low is $0.0550.

What is the market capitalization of Medipharm Labs Corp. Stock?
As of the Apr 23, 2024, the market capitalization of Medipharm Labs Corp. is 30.096M.
Click to get the best stock tips daily for free!

About Medipharm Labs Corp.

Medipharm Labs . MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is ... LABS.TO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT